Latest News

UCLA develops new method to detect DNA using cellphone technology

UCLA develops new method to detect DNA using cellphone technology

Nucleix secures CE mark for Bladder EpiCheck test

Israel-based cancer diagnostic tests company Nucleix has secured CE mark for marketing of its Bladder EpiCheck test in the European Union (EU)...

Nucleix secures CE mark for Bladder EpiCheck test

Personal Genome Diagnostics and VA extend cancer testing contract

Personal Genome Diagnostics (PGDx) has expanded its cancer testing contract with the US Department of Veterans Affairs (VA) to replace a previous tumour profiling assay with the new...

Personal Genome Diagnostics and VA extend cancer testing contract

Quansys, PATH develop new diagnostic tool to identify nutrition markers

Quansys Biosciences and non-profit health organisation PATH have developed a new multiplex diagnostic tool Q-Plex Micronutrient Array to fight against malnutrition and improve the health of...

Quansys, PATH develop new diagnostic tool to identify nutrition markers

FDA grants PMA to Siemens Healthineers' Versant HCV Genotype 2.0 Assay

The US Food and Drug Administration (FDA) has granted premarket approval (PMA) to Siemens Healthineers' Versant HCV Genotype 2.0 Assay (LiPA) to detect Hepatitis C virus...

FDA grants PMA to Siemens Healthineers' Versant HCV Genotype 2.0 Assay

Masimo secures CE mark for Rad-97 Pulse CO-Oximeter and connectivity hub NIBP

Masimo secures CE mark for Rad-97 Pulse CO-Oximeter and connectivity hub NIBP

Loxo enters into diagnostic collaboration with Roche's Ventana Medical Systems

US-based biopharmaceutical firm Loxo Oncology has entered into a collaboration agreement with Ventana Medical Systems, a division of Switzerland-based healthcare company Roche, to develop...

Loxo enters into diagnostic collaboration with Roche's Ventana Medical Systems

Prevencio develops new blood test to detect risk of cardiac disorders

Diagnostic tests provider Prevencio has developed a new multi-protein blood test HART CVE, in collaboration with Massachusetts General Hospital, to detect risk the of heart attack, stroke...

Prevencio develops new blood test to detect risk of cardiac disorders

Biocartis secures grant to develop MSI test for cancer detection

Biocartis secures grant to develop MSI test for cancer detection

Agena launches somatic mutation detection panels for lung and colon cancers

xGenetic analysis systems developer Agena Bioscience has launched targeted research panels UltraSEEK and iPLEX HS, for the detection of somatic mutations from lung and colon...

Agena launches somatic mutation detection panels for lung and colon cancers

Myriad Genetics introduces new test to assess breast cancer risk in US

Myriad Genetics introduces new test to assess breast cancer risk in US

Beckman Coulter obtains FDA clearance for new chemistry analyser

Beckman Coulter obtains FDA clearance for new chemistry analyser

Nogine to distribute Noventure’s Gelsectan in Spain, Portugal and Andorra

Norgine has signed an agreement to distribute Noventure's Gelsectan in Spain, Portugal and...

Nogine to distribute Noventure’s Gelsectan in Spain, Portugal and Andorra

Biocartis, Merck launch new liquid biopsy assay to detect mCRC

Biocartis, Merck launch new liquid biopsy assay to detect mCRC

Bristol-Myers Squibb, Grail partner to develop blood-based cancer screening

Pharmaceutical firm Bristol-Myers Squibb (BMS) has invested in life sciences company Grail to develop diagnostics for cancer...

Bristol-Myers Squibb, Grail partner to develop blood-based cancer screening

Velano's PIVO blood draw device secures third FDA 510(k) clearance

Medical device company Velano Vascular's needle-free blood draw device PIVO has secured 510(k) clearance from the US Food and Drug Administration...

Velano's PIVO blood draw device secures third FDA 510(k) clearance

bioMérieux secures FDA 510(k) clearance for Vidas Brahms PCT assay

French-based in-vitro diagnostics firm bioMérieux has secured 510(k) clearance from the US Food and Drug Administration (FDA) for the expanded use of its automated assay Vidas Brahms, to...

bioMérieux secures FDA 510(k) clearance for Vidas Brahms PCT assay

FDA grants 510(k) clearance to 7SBio's blood collection device

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Seventh Sense Biosystems' (7SBio) new push-button blood collection device...

FDA grants 510(k) clearance to 7SBio's blood collection device

DiaCarta gets CE-IVD for colorectal cancer test ColoScape

US-based molecular diagnostics company DiaCarta has secured CE-IVD approval for its new mutation detection kit ColoScape for the diagnosis of colorectal cancer...

DiaCarta gets CE-IVD for colorectal cancer test ColoScape

York Instruments, eemagine partner to develop MEG-EEG instrumentation and software

UK-based medical technology firm York Instruments has partnered with Germany-based medical device manufacturer eemagine Medical Imaging Solutions to develop integrated solutions...

York Instruments, eemagine partner to develop MEG-EEG instrumentation and software

Bioness secures FDA clearance for L300 Go system to diagnose gait

Medical technology company Bioness has secured the US Food and Drug Administration (FDA) clearance for the use of its L300 Go System to detect gait movement...

Bioness secures FDA clearance for L300 Go system to diagnose gait